I-Irebrin ingcono kune-dacarbazine kulayini ongemuva we-liposarcoma esezingeni eliphakeme

Yabelana ngalokhu okuthunyelwe

UGeorge D. Demetri kanye nabanye abavela e-American Dana Fabre / Briegen kanye Nesikhungo Somdlavuza Wesibhedlela Sabesifazane babike ukuthi phakathi kweziguli ezine-liposarcoma, ukusetshenziswa kwe-iriprine ekwelapheni okungemuva kuye kwathuthukisa kakhulu izinzuzo zokusinda ngaphezu kwe-dacarbazine. Ezigulini ezine-liposarcoma, into ebaluleke kakhulu ukukhetha ukwelashwa kwe-iribrin, ngoba uhlobo lwe-pathological lwesifo lunomphumela olinganiselwe ekusebenzeni kahle. (J Clin Oncol. Inguqulo ye-inthanethi ka-Agasti 30, 2017)

Ukuhlolwa komtholampilo kwesigaba III sangaphambilini kubonise ukuthi i-irribrin uma iqhathaniswa ne-dacarbazine ekwelapheni i-liposarcoma ethuthukisiwe noma i-leiomyosarcoma ingathuthukisa kakhulu ukusinda okuphelele (OS), futhi ukusabela okubi kulula ukuphatha nokulawula. Manje abacwaningi benza ukuhlaziywa kweqembu elingaphansi kwesimo seqembu le-iribulin neqembu le-dacarbazine, ngenhloso yokucacisa ukucaciswa kwezicubu ezifanele nokuphepha.

Izimo zokubhalisa: iminyaka yesiguli ≥18 iminyaka; i-liposarcoma ethuthukisiwe noma ethuthukisiwe engelapheka ngokuhlinzwa noma nge-radiotherapy; Isikolo sesimo sokusebenza se-ECOG ≤2; imithi yangaphambili ye-chemotherapy ≥2, kuhlanganise ne-anthracycline. Iziguli zahlukaniswa ngokungahleliwe zaba yiqembu le-erebrin (1.4 mg / m2, d1, 8) noma iqembu le-dacarbazine (850 mg / m2, 1000 mg / m2, noma 1200 mg / m2, d1) ngesilinganiso esingu-1: 1. Izinsuku ezingama-21 ziwumjikelezo. Amaphoyinti okufunda afaka i-OS, i-progression-free survival (PFS), nokuphepha.

Imiphumela yabonisa ukuthi i-OS eqenjini elincane le-liposarcoma yathuthukiswa kakhulu. I-OS emaphakathi emaqenjini e-iribulin nawe-dacarbazine yayiyizinyanga ezingu-15.6 nezinyanga ezingu-8.4 ngokulandelanayo (HR = 0.51, 95% CI 0.35 ~ 0.75; P <001). Eqenjini le-iribulin, iziguli ezine-liposarcoma yazo zonke izinhlobo ze-histological neziguli kuzo zonke izifunda zithole ukuthuthukiswa kwe-OS. I-PFS emaphakathi yeziguli eqenjini le-erebrin yayiyizinyanga ezingu-2.9 nezinyanga ezingu-1.7 ngokuhlobene neqembu le-dacarbazine (HR = 0.52, 95% CI 0.35 ~ 0.78; P = 0.0015). Izenzakalo ezimbi zazifana phakathi kwamaqembu amabili.

Bhalisa ku-Newsletter yethu

Thola izibuyekezo futhi ungalokothi uphuthelwe ibhulogi evela kuCancerfax

Okuningi Okuzohlolwa

I-CAR T Cell Therapy Esekelwe Kubantu: Ukuphumelela Nezinselele
Ukwelashwa kwe-CAR T-Cell

I-CAR T Cell Therapy Esekelwe Kubantu: Ukuphumelela kanye Nezinselele

Ukwelashwa kwe-CAR T-cell okusekelwe kumuntu kuguqula ukwelashwa komdlavuza ngokushintsha izakhi zofuzo amaseli omzimba esiguli ukuze aqondise futhi abhubhise amaseli omdlavuza. Ngokusebenzisa amandla esimiso somzimba sokuzivikela ezifweni, lezi zindlela zokwelapha zinikeza ukwelashwa okunamandla futhi okuqondene nomuntu okungahle kube nokuxolelwa okuhlala isikhathi eside ezinhlotsheni ezihlukahlukene zomdlavuza.

Ukuqonda I-Cytokine Release Syndrome: Izimbangela, Izimpawu, Nokwelashwa
Ukwelashwa kwe-CAR T-Cell

Ukuqonda I-Cytokine Release Syndrome: Izimbangela, Izimpawu, Nokwelashwa

I-Cytokine Release Syndrome (CRS) iwukusabela kwamasosha omzimba okuvame ukubangelwa izindlela zokwelapha ezithile ezifana ne-immunotherapy noma i-CAR-T cell therapy. Kuhilela ukukhululwa ngokweqile kwama-cytokines, okubangela izimpawu ezisukela kumkhuhlane nokukhathala kuya ezinkingeni ezingase zibeke ukuphila engozini njengokulimala kwesitho. Ukuphatha kudinga ukuqapha ngokucophelela kanye namasu okungenelela.

Dinga usizo? Ithimba lethu likulungele ukukusiza.

Sifisela ukululama okusheshayo kothandekayo wakho futhi oseduze.

Qala ingxoxo
Siku-inthanethi! Xoxa Nathi!
Skena ikhodi
Sawubona,

Siyakwamukela kuCancerFax!

ICancerFax iyinkundla yokuphayona ezinikele ekuxhumaniseni abantu ababhekene nomdlavuza oseqophelweni eliphezulu ngemithi yokwelapha yamangqamuzana efana ne-CAR T-Cell therapy, ukwelashwa kwe-TIL, nezivivinyo zomtholampilo emhlabeni wonke.

Sazise ukuthi yini esingakwenzela yona.

1) Ukwelashwa komdlavuza phesheya?
2) Ukwelashwa kwe-CAR T-Cell
3) Umuthi wokugomela umdlavuza
4) Ukubonisana ngevidiyo eku-inthanethi
5) Ukwelashwa kweProton